On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
37° Feels Like: 28°
Wind: NE 15 mph Past 24 hrs - Precip: 0.07”
Current Radar for Zip

Today

Rain 38°

Tonight

Rain/Snow 31°

Tomorrow

Rain/Snow 46°

Alerts

AstraZeneca's diabetes drug Xigduo approved in Europe

LONDON (Reuters) - AstraZeneca said European regulators had approved Xigduo for type 2 diabetes, in what was the first green light for a fixed dose combination of a SGLT2 inhibitor and metformin.

The drug combines in a twice daily tablet Forxiga, a SGLT2 inhibitor that reduces the reabsorption of excess glucose, and metformin, a standard in treating the condition.

Xigduo was developed by the alliance in diabetes therapy between the British company and Bristol-Myers Squibb, the companies said on Wednesday. AstraZeneca will take full control of the unit later this quarter.

(Reporting by Paul Sandle; editing by Sarah Young)

Comments